1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL SYRINGE MARKET BY TYPE
5.1. Introduction
5.2. Insulin Syringe
5.3. Disposable Syringes
5.3.1. Conventional Syringe
5.3.1.1. Eccentric Tip Syringe
5.3.1.2. Catheter Tip Syringe
5.3.1.3. Luer Lock Syringe
5.3.2. Safety Syringes
5.3.3. Prefilled Syringes
5.4. Others
6. GLOBAL SYRINGE MARKET BY MATERIAL
6.1. Introduction
6.2. Glass
6.3. Plastic
6.4. Stainless Steel
7. GLOBAL SYRINGE MARKET BY SYRINGE SIZE
7.1. Introduction
7.2. Smaller Volume Syringe
7.3. Larger Volume Syringe
8. GLOBAL SYRINGE MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United States
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Others
8.5. Middle East & Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Becton, Dickinson and Company
10.2. B. Braun Melsungen
10.3. Terumo
10.4. Teleflex
10.5. Nipro
10.6. ICU Medical
10.7. Cardinal Health
10.8. HMD Healthcare
10.9. Hamilton Company
10.10. Advancecare Pharma USA
10.11. Baxter International
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES